StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Sennosides

HCID 5199
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
517-43-1
Standard-SMILES
O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O
InChIKey
IPQVTOJGNYVQEO-UHFFFAOYSA-N
Summenformel
C42H38O20
Durchschnittliche Molmasse
862,7 g/mol
Monoisotopische Masse
862,1956436

Überblick

Sennosides (also known as senna glycoside or senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Sennoside A, one of the sennosides present in the laxative medication, has recently proven effective in inhibiting the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV) reverse transcriptase.

Namen und Bezeichner

Bevorzugter Name
Sennosides
IUPAC
9-[2-carboxy-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid
Englischer Name
Senna, Cassia obovata, ext.
Summenformel
C42H38O20
Molmasse
0

Namen und Synonyme

SennosidesGlysennidLaxativeColonormNytilaxSankaijoExchange selectDocuset SodiumLaxative PillsLaxative SennaSenna GlycosideColistat Plus
Weitere Namen anzeigen
Ccris 7490SENNA EXTRACT 8%Einecs 285-393-9Senna extract CRSCassiaobovata ext.Cassia obovata extractExtracts of Sennae FoliumSenna, Cassia obovata, ext.Senna extract (Cassia obovata)9-[2-carboxy-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid
Gentle NatureSenna LiquidColon DetoxGeri-kotSenna PlusSenna-TabsNature's RemedySenna Lax

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,2
Polarare Oberfläche (TPSA)
348 Ų
H-Brücken-Donoren
12
H-Brücken-Akzeptoren
20
Frei drehbare Bindungen
9
Schwere Atome
62
Formalladung
0
Komplexität
1.550

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals

Pharmaceuticals -> Used in Switzerland

CosmeticsSkin conditioning

Physikochemische Eigenschaften

Kosmetik-Inhaltsstoffe Funktionen
SKIN CONDITIONING

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Danger

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 78 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

This chemical does not meet GHS hazard criteria for 66.7% (2 of 3) of all reports.

Warning

Gefahrenhinweise

Hazard Classes and Categories · 2 Einträge

Skin Sens. 1 (100%)

Acute Tox. 4 (33.3%)

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingBecause sennosides are ingested and their action occurs in the gut, it is generally not thought to be protein bound.
PharmacodynamicsSenna stimulates peristalsis and increases fecal water content to increase motility of feces through the large intestine.
Mechanism of Action · 1 Eintrag

Sennoside A and B, the components of senna, are metabolized by gut bacteria into the active metabolite rheinanthrone [DB13175]. Rheinanthrone [DB13175] appears to increase cyclooxegenase 2 (COX2) expression in macrophage cells leading to an increase in prostaglandin E2 (PGE2). This increase in PGE2 is associated with a decrease in aquaporin 3 expression in mucosal epithelial cells of the large intestine. A decrease in aquaporin 3 expression likely produces the laxative effect by restricting water reabsorption by the large intestine thereby increasing fecal water content. The exact mechanism by which rheinanthrone increases COX2 expression is unknown. Rheinanthrone [DB13175] also stimulates peristalsis in the large intestine although the mechanism behind this effect is unknown. Rhein [DB13174], another active metabolite is thought to excite submucosal acetylcholinergic neurons resulting in increased chloride and prostaglandin secretion. The movement of chloride ions into the large intestine would also help to draw water into the lumen.

Biological Half-LifeThe half life of radiolabelled intravenous sennoside B in rats was 8.568±0.651h.
Metabolism/Metabolites · 1 Eintrag

Sennosides A and B are metabolised to sennidins A and B by gut bacteria. Sennidins A and B are further metabolized to rheinanthrone [DB13175] by gut bacteria using beta-glucosidase. Rheinanthrone [DB13175] is absorbed into systemic circulation where 2.6% is metabolized to rhein [DB13174] and sennidins A and B via oxidation. Rheinanthrone [DB13175] is the major active metabolite of sennosides A and B which produces the laxative effect of the medication. Rhein [DB13174] is also an active metabolite known to have many protective effects.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
517-43-1、62211-03-4、66575-30-2、81-27-6、85085-71-8
PubChem CID
5199
DTXSID
DTXSID20859118
ChEMBL
CHEMBL2108559
EC Number
263-461-9、285-393-9、805-136-1
MeSH Pharmacological ClassificationAgents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION.
Absorption, Distribution and Excretion · 4 Einträge

<10% is absorbed from the gut mostly in the form of the active metabolite rheinanthrone [DB13175].

3-6% of metabolites are excreted in urine with some in bile. >90% of sennosides are excreted in the feces as polymers with 2-6% of the parent compounds excreted unchanged.

The volume of distribution of radiolabelled intravenous sennoside B in rats was 0.802±0.124L/kg.

The clearance of radiolabelled intravenous sennoside B in rats was 0.065±0.007L/h/kg.

Verwendung und Herstellung

Use ClassificationCosmetics -> Skin conditioning

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

1,8-Dihydroxy-3-(hydroxymethyl)anthrachinonSennosid ASennosid BTannine